Literature DB >> 8178571

Synthesis of recombinant baculoviruses expressing the outer capsid protein VP2 of five BTV serotypes and the induction of neutralizing antibodies to homologous and heterologous BTV serotypes.

T Urakawa1, T J French, Y Adachi, A Fukusho, H LeBlois, M Flamand, P Mertens, P Roy.   

Abstract

DNA representing RNA segment L2 of 5 different bluetongue virus (BTV) serotypes (BTV-1, -2, -11, -13 and -17) corresponding to the gene that codes for the BTV neutralization antigen VP2, have been inserted individually into baculovirus transfer vectors in lieu of the 5' coding region of the polyhedrin gene of Autographa california nuclear polyhedrosis virus (AcNPV). After co-transfection of Spodoptera frugiperda cells with wild-type AcNPV DNA in the presence of the derived transfer vector DNAs, polyhedrin-negative recombinant baculoviruses were recovered. When S. frugiperda cells were infected with each of these viruses, protein was made similar in size and antigenic properties to the authentic BTV VP2 protein. To evaluate the biological activities of these proteins, antibodies were raised to them in guinea pigs. The neutralization capabilities of these antisera were tested against homologous and, for two of the higher titered sera, heterologous BTV serotypes. Each antiserum neutralized the infectivity of the homologous virus serotype. In heterologous virus challenges, the serum raised to the VP2 protein of BTV-13 also neutralized the infectivity of BTV-1, and to lesser extents BTV-3, -16, -8 and -9 (BTV-2, -10, -11, -15 were not tested). The serum raised to the VP2 of BTV-17 neutralized BTV-20 and -21, and to lesser extents BTV-4 and -8 (again, BTV-2, -10, -11, -15 were not tested).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178571     DOI: 10.1016/0168-1702(94)90001-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain.

Authors:  Bishnupriya Bhattacharya; Polly Roy
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

2.  Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress.

Authors:  Bishnupriya Bhattacharya; Rob J Noad; Polly Roy
Journal:  Virol J       Date:  2007-01-15       Impact factor: 4.099

3.  Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.

Authors:  Yuta Kanai; Piet A van Rijn; Mieke Maris-Veldhuis; Yuki Kaname; T N Athmaram; Polly Roy
Journal:  Vaccine       Date:  2014-07-18       Impact factor: 3.641

4.  Development of plant-produced protein body vaccine candidates for bluetongue virus.

Authors:  Albertha R van Zyl; Ann E Meyers; Edward P Rybicki
Journal:  BMC Biotechnol       Date:  2017-05-30       Impact factor: 2.563

5.  Soluble expression and purification of Bluetongue Virus Type 1 (BTV1) structure protein VP2 in Escherichia coli and its immunogenicity in mice.

Authors:  Aiping Wang; Jiajia Yin; Jingming Zhou; Hongfang Ma; Yumei Chen; Hongliang Liu; Yanhua Qi; Chao Liang; Yankai Liu; Jinge Li; Gaiping Zhang
Journal:  PeerJ       Date:  2021-01-04       Impact factor: 2.984

6.  Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR -/- mice.

Authors:  Petra C Fay; Houssam Attoui; Carrie Batten; Fauziah Mohd Jaafar; George P Lomonossoff; Janet M Daly; Peter P C Mertens
Journal:  Vaccine X       Date:  2019-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.